Clinical Trials Browser

Carcinoma, Merkel Cell × Opdualag × 90 days × Clear all

NCT06151236 2026-02-17

Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma

Phase 2 Recruiting

Carcinoma, Merkel Cell